The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer.
Talia M, Cirillo F, Scordamaglia D, Di Dio M, Zicarelli A, De Rosis S, Miglietta AM, Capalbo C, De Francesco EM, Belfiore A, Grande F, Rizzuti B, Occhiuzzi MA, Fortino G, Guzzo A, Greco G, Maggiolini M, Lappano R.
Talia M, et al. Among authors: guzzo a.
J Exp Clin Cancer Res. 2024 Jun 18;43(1):171. doi: 10.1186/s13046-024-03096-7.
J Exp Clin Cancer Res. 2024.
PMID: 38886784
Free PMC article.